• Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

EQL Pharma recruits Oskar Karmlid as new Chief Supply Chain Officer (CSCO)

EQLSelskabsmeddelelse27.07.2026, 13.51
Download udgivelse

EQL has recruited Oskar Karmlid as its new Chief Supply Chain Officer (CSCO). Oskar will join the team in October 2026 and take over from Martin Kristofferson, who currently leads supply chain on interim basis.

Oskar has spent most of his professional career in consulting, focusing on supply chain and operations. Throughout his career, he has worked with building and developing end-to-end supply chains, improving planning and cross-functional ways of working, driving supplier and logistics set-ups, creating more efficient and scalable processes, and coaching clients throughout these projects and processes. Prior to his consulting career, Oskar spent three years at SOVA, in various supply chain and logistics roles.

CEO Axel Schörling comments

"To me, the recruitment of Oskar completes the upgrade of EQL's management team, with the clear target to prepare the company for its next growth phase. We are currently experiencing challenges across our supply chain which need to be addressed structurally, focusing on upgrading and enhancing internal processes and systems. Oskar's deep knowledge within supply chain, coupled with his analytical can-do attitude, will be instrumental assets for EQL, in its ambitions to create robust and scalable foundation."

Oskar comments:

"'I'm very glad and enthusiastic about joining EQL Pharma. This role gives me the chance to work both strategically and hands-on, bringing together the knowledge and experience I've built over years in consulting with the opportunity to be closer to execution and drive real, lasting impact. I look forward to rolling up my sleeves and contributing to building an efficient, end-to-end, future-proof supply chain - one that supports and accelerates EQL's strategy and growth journey. I'm excited to work closely with the team and to be part of shaping this exciting development ahead."